ATE22804T1 - Pharmazeutische zusammensetzung. - Google Patents
Pharmazeutische zusammensetzung.Info
- Publication number
- ATE22804T1 ATE22804T1 AT83300621T AT83300621T ATE22804T1 AT E22804 T1 ATE22804 T1 AT E22804T1 AT 83300621 T AT83300621 T AT 83300621T AT 83300621 T AT83300621 T AT 83300621T AT E22804 T1 ATE22804 T1 AT E22804T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- niacin
- gamma
- administered
- compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 1
- 239000003833 bile salt Substances 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 235000004626 essential fatty acids Nutrition 0.000 abstract 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract 1
- 229960002733 gamolenic acid Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960003512 nicotinic acid Drugs 0.000 abstract 1
- 235000001968 nicotinic acid Nutrition 0.000 abstract 1
- 239000011664 nicotinic acid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
- Confectionery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8205935 | 1982-03-01 | ||
| EP83300621A EP0087864B1 (de) | 1982-03-01 | 1983-02-08 | Pharmazeutische Zusammensetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE22804T1 true ATE22804T1 (de) | 1986-11-15 |
Family
ID=10528692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT83300621T ATE22804T1 (de) | 1982-03-01 | 1983-02-08 | Pharmazeutische zusammensetzung. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0087864B1 (de) |
| JP (1) | JPS58159414A (de) |
| AT (1) | ATE22804T1 (de) |
| AU (1) | AU563273B2 (de) |
| CA (1) | CA1197784A (de) |
| DE (1) | DE3366838D1 (de) |
| IE (1) | IE54556B1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62106019A (ja) * | 1985-11-01 | 1987-05-16 | Terumo Corp | 抗高脂血症剤 |
| GB8603621D0 (en) * | 1986-02-14 | 1986-03-19 | Habib N | Modifying lipid structure of cell membranes |
| US4965252A (en) * | 1988-06-28 | 1990-10-23 | Hauser-Kuhrts, Inc. | Cholesterol-lowering combination compositions of guar gum and niacin |
| DE3782255T2 (de) * | 1987-12-14 | 1993-04-22 | Amer & Co | Cholestyraminzusammensetzungen und verfahren zu ihrer herstellung. |
| DE4402379C2 (de) * | 1994-01-27 | 1997-09-25 | Lohmann Therapie Syst Lts | Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung |
| GB9403855D0 (en) * | 1994-03-01 | 1994-04-20 | Scotia Holdings Plc | Fatty acid derivatives |
| AU713045B2 (en) * | 1995-05-01 | 1999-11-25 | Scarista Limited | Nicotinic acid esters and pharmaceutical compositions containing them |
| USRE40546E1 (en) * | 1996-05-01 | 2008-10-21 | Scarista, Ltd. | 1,3-Propane diol esters and ethers and methods for their use in drug delivery |
| MY118354A (en) * | 1995-05-01 | 2004-10-30 | Scarista Ltd | 1,3-propane diol derivatives as bioactive compounds |
| GB9724840D0 (en) * | 1997-11-26 | 1998-01-21 | Kappa Pharmaceuticals Ltd | Reduced blood cholesterol |
| CA2436650A1 (en) | 2003-08-06 | 2005-02-06 | Naturia Inc. | Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses |
| GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
| US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
| CN107072959A (zh) | 2014-06-04 | 2017-08-18 | 尊严科学有限公司 | 包含二高γ亚麻酸(DGLA)的医药组合物以及其用途 |
| US20210315851A1 (en) | 2020-04-03 | 2021-10-14 | Afimmune Limited | Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases |
-
1983
- 1983-02-08 DE DE8383300621T patent/DE3366838D1/de not_active Expired
- 1983-02-08 AT AT83300621T patent/ATE22804T1/de not_active IP Right Cessation
- 1983-02-08 EP EP83300621A patent/EP0087864B1/de not_active Expired
- 1983-02-09 IE IE263/83A patent/IE54556B1/en not_active IP Right Cessation
- 1983-02-14 CA CA000421504A patent/CA1197784A/en not_active Expired
- 1983-02-16 AU AU11456/83A patent/AU563273B2/en not_active Ceased
- 1983-02-28 JP JP58032684A patent/JPS58159414A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA1197784A (en) | 1985-12-10 |
| DE3366838D1 (en) | 1986-11-20 |
| JPS58159414A (ja) | 1983-09-21 |
| IE830263L (en) | 1983-09-01 |
| AU563273B2 (en) | 1987-07-02 |
| EP0087864A3 (en) | 1984-03-21 |
| IE54556B1 (en) | 1989-11-22 |
| EP0087864A2 (de) | 1983-09-07 |
| AU1145683A (en) | 1983-09-08 |
| EP0087864B1 (de) | 1986-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE96313T1 (de) | Fettsaeure-zusammensetzungen. | |
| ATE22804T1 (de) | Pharmazeutische zusammensetzung. | |
| GR3006068T3 (de) | ||
| DE2967049D1 (en) | Pharmaceutical and dietary composition comprising gamma-linolenic acids | |
| DE2961102D1 (en) | Pharmaceutical and dietary composition comprising gamma-linolenic acids | |
| NO940277L (no) | Triglycerider og blandinger av slike | |
| IL72381A0 (en) | Pharmaceutical composition based on valproic acid | |
| DE3669882D1 (de) | 2-zyanakrylsaeureester enthaltende zusammensetzung. | |
| ATE22532T1 (de) | Pharmazeutische zusammensetzung. | |
| EP0175468A3 (de) | Eicosanoide zur Verwendung bei der Krebstherapie | |
| AU633603B2 (en) | Pharmaceutical compositions | |
| ATE22533T1 (de) | Pharmazeutische zusammensetzung. | |
| DE3778132D1 (de) | 2-beta-substituierte methylpenicillansaeure-derivate und deren salze und ester. | |
| ES474408A1 (es) | Procedimiento para la obtencion de 1,4-dihidropiridinas con agrupaciones ester sulfurosas | |
| IL92357A0 (en) | Pharmaceutical compositions containing an antibacterial compound and an absorption enhancing system | |
| EP0302481A3 (de) | Verwendung von freien Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von Diabetes mellitus | |
| ATE19855T1 (de) | Pharmazeutische und diaetetische zusammensetzung. | |
| AU570552B2 (en) | 1,4-dihydropyridine-3-carboxylates and salts thereof | |
| ZA834409B (en) | 1,4-dihydropyridine derivatives in optically active or in racemate form and their production and pharmaceutical compositions | |
| DE69121058D1 (de) | Salze von Glykosaminoglykanen mit Aminosäureester, ihre Herstellung sowie sie enthaltende pharmazeutische Zusammensetzungen | |
| DE2967551D1 (en) | 5(6)-(2-amino-5-thiazoloyl)benzimidazole-2-carbamic acid esters and their salts, their preparation and use, and pharmaceutical compositions containing them | |
| GB8719670D0 (en) | Pharmaceutical compositions | |
| EP0089198A3 (de) | Nichttoxische Aspirin enthaltende Zusammensetzung | |
| RU94002319A (ru) | Триглицериды |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |